EN
EN
CN
JP
KR
MOUSE MODELS
MOUSE MODELS
Knockout & Conditional Knockout Mouse Models
Disease Mouse Models
Germ-Free Mouse Models
Tool Mice
Immunodeficient Mouse Models
The Wild Mouse Project
NeoMab® Fully-human Antibody Transgenic Mouse
SERVICES
SERVICES
Custom Model Generation Services
Preclinical Testing Services
Germ-Free and Microbiome Services
Cell Lines and Customization Services
Patient Derived Xenograft (PDX) Mouse Models and Efficacy Services
Custom Breeding Services
Animal Quality Testing Services
NeoMab® Fully-Human Antibody Discovery Service
Assay Capabilities
Other Services
RESOURCES
RESOURCES
Webinars
Posters
Blogs
NEWS & EVENTS
NEWS & EVENTS
News
Events
ABOUT US
ABOUT US
GemPharmatech USA
GemPharmatech Headquarters
Facilities
Careers
Contact Us
Quality Management System
BALB/c Mice with Humanized VISTA: A Novel GEMM for Preclinical Evaluation of Therapeutic Antibodies against VISTA
March 30, 2022
*
*
*
*
COUNTRY/REGION
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrian
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bonaire, Sint Eustatius and Saba
Bosnia Hercegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Is
Central African
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Is
Costa Rica
Cote d'lvoire
Croatia
Cuba
Curaçao
Cyprus
Czech
Denmark
Djibouti
Dominica
Dominican
DR Congo
East Timor
Ecuador
Egypt
El Salvador
Eq.Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guam
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kirghizia
Kiribati
Korea
Korea,DPR
Kosovo
Kuwait
Laos
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jm
Liechtenstein
Lithuania
Luxembourg
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Is Rep
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldavia
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthélemy
Saint Helena
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Sint Maarten
Slovak
Slovenia
Solomon Is
Somalia
South Africa
South Georgia and The South Sandwich Islands
Spain
Sri Lanka
St Kitts-Nevis
St.Pierre and Miquelon
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syrian
Tajikistan
Tanzania
Thailand
The British Virgin Islands
The United States Virgin Islands
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekstan
Vanuatu
Vatican City State
Venezuela
Vietnam
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe
*
STATE/PROVINCE
*
Next :
BALB/c-hPD1/hGITR: A Novel Mouse Model for Preclinical Evaluation of Anti-GITR and Anti-PD1 Therapies
Previous：
CD137 Humanized Mice for Preclinical Efficacy Evaluation of anti-CD137 Therapeutic Antibodies
0
Inquiry
Contact Us
RESOURCES
Posters
